家用輸液治療市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Home Infusion Therapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月12日 | 出版商:

Global Market Insights Inc. | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於慢性病盛行率上升和人口老化，家庭輸液治療市場規模預計 2024 年至 2032 年複合年成長率將達到 11%。報告表明，大約三分之一的成年人患有多種慢性病。隨著糖尿病、癌症和心血管問題等疾病的日益流行，對持續和客製化治療解決方案的需求不斷增加。居家輸液治療為患者在家中接受基本藥物和治療提供了一種方便有效的方法，最大限度地減少了頻繁去醫院的必要性。

輸液技術的最新進展，特別是攜帶式和方便用戶使用型輸液泵，徹底改變了家庭藥物管理。此外，專業輸液服務的不斷增加，加上專業的醫療保健支持，增強了居家輸液治療的安全性和可行性。

整個產業分為產品、應用、區域。

從產品來看，無針連接器領域的家庭輸液治療市場預計從 2024 年到 2032 年將出現顯著的複合年成長率，因為它們能夠提高安全性和易用性。透過在給藥過程中消除針頭，無針連接器大大降低了針刺傷害和感染的風險，這在家庭護理環境中是一個至關重要的優勢。它們的使用者友善性確保了更順暢、更衛生的用藥管理，從而提高患者的舒適度和對治療方案的依從性。

水化療法應用領域的家庭輸液療法市場價值預計將從 2024 年到 2032 年上升。水合療法擴大在家中進行，以提高患者的舒適度和便利性。

預計亞太地區家庭輸液治療產業將在 2024 年至 2032 年間呈現利潤豐厚的成長。隨著糖尿病、癌症和心血管疾病等疾病在該地區日益突出，對家庭治療解決方案的需求也隨之增加。

產業生態系統分析
產業影響力
- 成長動力
  - 院內感染不斷增加
  - 慢性病盛行率上升
  - 技術進步
  - 老年人口不斷增加
  - 人們越來越偏好家庭醫療保健解決方案
- 產業陷阱與挑戰
  - 缺乏報銷
  - 與家用輸液裝置相關的安全問題和故障風險
成長潛力分析
監管環境
家庭輸液治療行業趨勢
差距分析
波特的分析
PESTEL分析
家庭輸液治療產業未來前景

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
點滴幫浦
靜脈注射套
靜脈插管
無針頭連接器

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
抗感染
水合療法
化療
腸內營養
腸外營養
特種藥品
其他應用

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

AMERITA INC.
Amsino International, Inc.
B. Braun Melsungen AG
Baxter International Inc.
Becton Dickinson and Company
Contec Medical Systems Co. Ltd
Erenler Medikal
Fresenius Kabi
Halyard Health, Inc. (Avanos Medical)
ICU Medical Inc.
JMS Co. Ltd.
Lepu Medical Technology
Moog Inc.
Option Care Health, Inc.
Terumo Corporation

簡介目錄

Product Code: 435

Home infusion therapy market size is anticipated to record an 11% CAGR from 2024 to 2032 led by the rising prevalence of chronic diseases and an aging population. Reports indicate that approximately one in three adults grapple with multiple chronic conditions. With the increasing prevalence of diseases like diabetes, cancer, and cardiovascular issues, there is a heightened demand for continuous and tailored treatment solutions. Home infusion therapy provides a convenient and effective means for patients to receive essential medications and treatments right at home, minimizing the necessity for frequent hospital visits.

Recent advancements in infusion technology, particularly portable and user-friendly infusion pumps, have revolutionized medication management at home. Furthermore, the growing availability of specialized infusion services, coupled with professional healthcare support, bolsters the safety and feasibility of home infusion therapy.

The overall industry is divided into product, application, and region.

Based on product, the home infusion therapy market from the needleless connectors segment is expected to record a significant CAGR from 2024 to 2032 due to their ability to enhance safety and ease of use. By eliminating needles during medication administration, needleless connectors drastically lower the risk of needle-stick injuries and infections, a crucial advantage in home care settings. Their user-friendly nature ensures smoother, more hygienic medication administration, thereby enhancing patient comfort and adherence to treatment protocols.

Home infusion therapy market value from the hydration therapy application segment is projected to rise from 2024 to 2032. This is owing to its essential role in managing dehydration and supporting patients with chronic conditions or undergoing intensive treatments. Hydration therapy is increasingly being provided at home to improve patient comfort and convenience.

Asia Pacific home infusion therapy industry is projected to exhibit lucrative growth between 2024 and 2032. This surge is driven by a rising prevalence of chronic diseases, an expanding elderly demographic, and notable advancements in healthcare infrastructure. As conditions like diabetes, cancer, and cardiovascular diseases gain prominence in the region, the appetite for home-based treatment solutions intensifies.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing hospital acquired infections
  - 3.2.1.2 Rising prevalence of chronic diseases
  - 3.2.1.3 Advancements in technology
  - 3.2.1.4 Growing geriatric population
  - 3.2.1.5 Increasing preference towards at-home healthcare solutions
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Dearth of reimbursement
  - 3.2.2.2 Safety concerns and risk of failure associated with home infusion devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Trends in home infusion therapy industry
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future prospects for home infusion therapy industry

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Infusion pumps
5.3 Intravenous sets
5.4 IV cannulas
5.5 Needleless connectors

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Anti-infective
6.3 Hydration therapy
6.4 Chemotherapy
6.5 Enteral nutrition
6.6 Parenteral nutrition
6.7 Specialty pharmaceuticals
6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa